Advancing Epidermal Barrier Resilience in Atopic Dermatitis with Isosorbide Di-Fatty Acid Esters: From Disruption to Restoration
Open Access
- 27 August 2026
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1246
Abstract
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease characterized by epidermal barrier dysfunction, immune dysregulation, microbial imbalance, and severe pruritus. Emerging evidence establishes that barrier disruption is a central pathogenic driver capable of initiating inflammatory signaling, neuroimmune activation, and chronic disease instability. This understanding has shifted therapeutic paradigms toward barrier-directed strategies aimed at restoring epidermal resilience. This narrative review evaluates the mechanistic and clinical evidence surrounding isosorbide fatty acid diester molecules—specifically isosorbide dicaprylate (IDC) and isosorbide di-(linoleate/oleate) (IDL)—as a barrier-first approach for AD management. Early in vitro and ex vivo investigations demonstrated that IDC significantly improves epidermal hydration, transepidermal water loss, and the expression of barrier-associated genes linked to epidermal integrity. Subsequent studies showed that IDL expands these effects through coordinated regulation of keratinocyte differentiation, lipid homeostasis, and inflammatory stress pathways. Furthermore, recent mechanistic data highlight synergistic anti-inflammatory and pruritus-modulating effects involving TRPA1-, TRPV3-, and TSLP-associated pathways, while preserving tissue integrity under cytokine-induced stress. Clinically, these findings are supported by randomized studies in pediatric and adult cohorts demonstrating significant reductions in pruritus, favorable Eczema Area and Severity Index (EASI) responses, decreased topical corticosteroid dependence, and a reduction in the relative abundance of Staphylococcus aureus. Collectively, these findings support a barrier-first therapeutic framework in which restoration of epidermal resilience may beneficially influence multiple interconnected pathways involved in atopic dermatitis.Keywords
This publication has 49 references indexed in Scilit:
- Transcriptional dysregulation of skin barrier genes in atopic dermatitis and psoriasis: Mechanistic insights and emerging therapeutic strategiesBiomedicine & Pharmacotherapy, 2025
- Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatmentJournal of Allergy and Clinical Immunology, 2023
- Biomarkers in atopic dermatitis—a review on behalf of the International Eczema CouncilJournal of Allergy and Clinical Immunology, 2021
- Granzyme B Contributes to Barrier Dysfunction in Oxazolone-Induced Skin Inflammation through E-Cadherin and FLG CleavageJournal of Investigative Dermatology, 2021
- Cellular and molecular immunologic mechanisms in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2016
- The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce ItchCell, 2013
- MicroRNAs: Essential players in the regulation of inflammationJournal of Allergy and Clinical Immunology, 2013
- Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysisJournal of Allergy and Clinical Immunology, 2009
- Skin barrier functionCurrent Allergy and Asthma Reports, 2008
- A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activityJournal of Immunological Methods, 1988